procaterol has been researched along with Action Tremor in 6 studies
Procaterol: A long-acting beta-2-adrenergic receptor agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tremor, the most common side effect of ordinary doses of beta 2-agonists, was evaluated in a quantitative manner and compared to improvement in pulmonary function in respect to time of onset, duration, peak effect, and tachyphylaxis with procaterol in adults." | 9.06 | Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma. ( DeJong, R; Lutz, C; Spangler, DL; Tinkelman, DG, 1990) |
| "Procaterol, a new beta-2 adrenoceptor stimulant, was studied in a double-blind, placebo-controlled, cross-over trial in patients with bronchial asthma." | 9.05 | Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study. ( Dahl, R; Harving, H; Henriksen, J; Rønne, K; Schøler, P, 1985) |
| "5 micrograms/kg dosage may, however, be a good starting dose because it assures a reasonable risk/benefit ratio." | 6.67 | Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages. ( Boner, AL; Miglioranzi, P; Piacentini, G; Richelli, C; Sette, L; Zanotto, CE, 1990) |
| "For clenbuterol, the same was also observed in comparison with placebo, while for procaterol this was true only for FEV1 and FEF25-75, while no difference resulted from FVC and PEF." | 6.66 | Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma. ( Boner, AL; Castellani, C; Schiassi, M; Sette, L, 1987) |
| "Tremor, the most common side effect of ordinary doses of beta 2-agonists, was evaluated in a quantitative manner and compared to improvement in pulmonary function in respect to time of onset, duration, peak effect, and tachyphylaxis with procaterol in adults." | 5.06 | Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma. ( DeJong, R; Lutz, C; Spangler, DL; Tinkelman, DG, 1990) |
| "The efficacy and safety of orally administered procaterol hydrochloride, a potent beta 2-adrenergic bronchodilator, was compared with that of albuterol in an eight-center, double-blind study conducted in 223 patients with mild to moderate, reversible bronchial airway obstruction." | 5.06 | A comparison of oral procaterol and albuterol in reversible airflow obstruction. ( Beaupre, A; Boulet, LP; Brandon, ML; Busse, WW; Chervinsky, P; Mazza, J; Petty, TL; Schoenweter, W, 1988) |
| "Procaterol, a new beta-2 adrenoceptor stimulant, was studied in a double-blind, placebo-controlled, cross-over trial in patients with bronchial asthma." | 5.05 | Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study. ( Dahl, R; Harving, H; Henriksen, J; Rønne, K; Schøler, P, 1985) |
| "5 micrograms/kg dosage may, however, be a good starting dose because it assures a reasonable risk/benefit ratio." | 2.67 | Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages. ( Boner, AL; Miglioranzi, P; Piacentini, G; Richelli, C; Sette, L; Zanotto, CE, 1990) |
| "Procaterol hydrochloride is a new sympathomimetic amine which is highly selective for beta-2 receptors." | 2.66 | Procaterol metered-dose inhaler in adults with asthma. ( Bodman, SF; Nathan, RA; Storms, WW; Wilson, JM, 1985) |
| "For clenbuterol, the same was also observed in comparison with placebo, while for procaterol this was true only for FEV1 and FEF25-75, while no difference resulted from FVC and PEF." | 2.66 | Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma. ( Boner, AL; Castellani, C; Schiassi, M; Sette, L, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tinkelman, DG | 1 |
| DeJong, R | 1 |
| Lutz, C | 1 |
| Spangler, DL | 1 |
| Boner, AL | 2 |
| Zanotto, CE | 1 |
| Piacentini, G | 1 |
| Miglioranzi, P | 1 |
| Richelli, C | 1 |
| Sette, L | 2 |
| Storms, WW | 1 |
| Bodman, SF | 1 |
| Nathan, RA | 1 |
| Wilson, JM | 1 |
| Dahl, R | 1 |
| Harving, H | 1 |
| Henriksen, J | 1 |
| Rønne, K | 1 |
| Schøler, P | 1 |
| Castellani, C | 1 |
| Schiassi, M | 1 |
| Petty, TL | 1 |
| Brandon, ML | 1 |
| Busse, WW | 1 |
| Chervinsky, P | 1 |
| Schoenweter, W | 1 |
| Beaupre, A | 1 |
| Boulet, LP | 1 |
| Mazza, J | 1 |
6 trials available for procaterol and Action Tremor
| Article | Year |
|---|---|
Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Asthma; Clinical Trials as Topic; Dose-Respon | 1990 |
Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages.
Topics: Administration, Oral; Asthma; Bronchodilator Agents; Child; Dose-Response Relationship, Drug; Drug A | 1990 |
Procaterol metered-dose inhaler in adults with asthma.
Topics: Adult; Aerosols; Aged; Clinical Trials as Topic; Ethanolamines; Evaluation Studies as Topic; Female; | 1985 |
Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study.
Topics: Adolescent; Adult; Aged; Asthma; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Femal | 1985 |
Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
Topics: Administration, Oral; Asthma; Bronchodilator Agents; Child; Clenbuterol; Double-Blind Method; Ethano | 1987 |
A comparison of oral procaterol and albuterol in reversible airflow obstruction.
Topics: Administration, Oral; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Clinical Trials | 1988 |